Citation 65986

SHOJI,JI: HINOO,H: KATO,T: HATTORI,T: HIROOKA,K: TAWARA,K: SHIRATORI,O: TERUI,Y:. (1990). ISOLATION OF CEPAFUNGINS I, II AND III FROM PSEUDOMONAS SPECIES.. 43(7)

Citation Details

TitleISOLATION OF CEPAFUNGINS I, II AND III FROM PSEUDOMONAS SPECIES.
AuthorsSHOJI,JI: HINOO,H: KATO,T: HATTORI,T: HIROOKA,K: TAWARA,K: SHIRATORI,O: TERUI,Y:
Year1990
Volume43
Issue7

Summary

Year: 1990

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE
2
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE
3
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE
4
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
INACTIVE
5
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE
6
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE
7
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE
8
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE
9
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CEPAFUNGIN
ACTIVE
10
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN
ACTIVE

Pseudomonas species (PSEUDOMONADACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CEPAFUNGIN I
None
2
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
3
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
4
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
5
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
INACTIVE
6
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
7
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
8
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
9
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
10
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CEPAFUNGIN I
ACTIVE
11
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN I
ACTIVE
12Not specified
UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
GLIDOBACTIN A
None
13
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
14
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
15
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
16
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
INACTIVE
17
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
18
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
19
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
20
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
21
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
GLIDOBACTIN A
ACTIVE
22
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
GLIDOBACTIN A
ACTIVE
23Not specified
UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CEPAFUNGIN III
None
24
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
25
ANTIYEAST ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
26
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
27
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
INACTIVE
28
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
29
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
30
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
31
ANTIFUNGAL ACTIVITY
EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
32
ANTITUMOR ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CEPAFUNGIN III
ACTIVE
33
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CEPAFUNGIN III
ACTIVE
Show SPARQL Queries (1)